57 related articles for article (PubMed ID: 2508283)
1. [Activity of norfloxacin against gram-negative bacteria].
Ben Redjeb S; Ennaifer M; Kechrid A; Ben Hassen A; Boujnah A
Tunis Med; 1989; 67(6-7):391-5. PubMed ID: 2508283
[No Abstract] [Full Text] [Related]
2. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates.
Qadri SM; Lee G; Brodie L
Drugs Exp Clin Res; 1989; 15(8):349-53. PubMed ID: 2598776
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of norfloxacin in enteric and urinary tract infections: combined effect of norfloxacin with aminoglycosides, tetracycline and chloramphenicol.
Mascellino MT; Lorenzi A; Bonanni M; Iegri F
Drugs Exp Clin Res; 1986; 12(4):319-23. PubMed ID: 3720519
[TBL] [Abstract][Full Text] [Related]
5. [Activity of selected cephalosporin antibiotics against clinical strains of gram-negative bacteria].
Dzierzanowska D; Kaźmirowska Z; Kołodziejczyk J; Lawicka K; Mészaros J
Pol Tyg Lek; 1987 Dec; 42(49):1539-41. PubMed ID: 3131750
[No Abstract] [Full Text] [Related]
6. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
Campos P; Vera A; Martin-Luengo F
Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
[No Abstract] [Full Text] [Related]
7. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
8. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Berardi-Grassias LD; Roy O
Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of urinary pathogens to quinolones compared to other antimicrobial agents.
Osman LM; Sabbour MS; el-Baz F
Chemioterapia; 1987 Jun; 6(2 Suppl):147-8. PubMed ID: 3151335
[No Abstract] [Full Text] [Related]
10. [In vitro activity of azthreonam (SQ 26.776) against Gram-negative bacteria].
Landínez RJ; García Castro MA; Coladas N; Bratos MA; Kastanos N; Alvarez Alonso E
Med Clin (Barc); 1984 Jan; 82(3):106-9. PubMed ID: 6431206
[No Abstract] [Full Text] [Related]
11. Antibacterial activity and pharmacokinetics in mice of two new derivatives of norfloxacin.
Balsari A; Dubini F; Stradi R; Riviera L
Chemioterapia; 1987 Jun; 6(2 Suppl):176-8. PubMed ID: 3509384
[No Abstract] [Full Text] [Related]
12. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
14. 1-Chloropiperazinic derivative (ER 311) of norfloxacin: antibacterial activity in vitro and pharmacokinetic properties in mice.
Dubini F; Balsari A; Stradi R; Riviera L
Chemioterapia; 1987 Jun; 6(2 Suppl):178-80. PubMed ID: 3509385
[No Abstract] [Full Text] [Related]
15. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
Debbia E; Schito GC; Nicoletti G; Speciale A
Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
[No Abstract] [Full Text] [Related]
18. In vitro activity of norfloxacin against multi-resistant bacteria.
Machka K; Vogelsang G
Eur J Clin Microbiol; 1983 Jun; 2(3):270-1. PubMed ID: 6224686
[No Abstract] [Full Text] [Related]
19. [Gram-negative conditionally pathogenic microflora in hospitals and its resistance to chloramine].
Trukhina GM; Sokolova NF; Ioĭrish AN; Smirnova MN
Gig Sanit; 1985 May; (5):82-4. PubMed ID: 3928447
[No Abstract] [Full Text] [Related]
20. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Mascellino MT; Prignano G; Iegri F; Lorenzi A
Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
